CNCE Stock Forecast & Price Target
CNCE Stock
Price Forecast
The average stock forecast for
Concert Pharmaceuticals Inc (CNCE) in the next 12 months is 11.90 USD. This price target corresponds to an upside
of
42.17%. The range of stock forecasts for CNCE is 9.09 - 17.85 USD.
Based on the ratings of 11 analysts, the consensus recommendation for CNCE is
HOLD.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
9.09 |
11.90 |
9.18 |
17.85 |
| Upside |
8.60% |
42.17% |
9.68% |
113.26% |
Recommendation Trends
The latest consensus rating for CNCE is "HOLD". This is the average
recommendation of 11 analysts: 0 strong sell,
0 sell, 4 hold, 4 buy, 3 strong buy. In the previous period, 11 analysts also majorly recommmended
"BUY" for CNCE.
CNCE Financial Stock
Forecast
Revenue This Year
from 32.58M
Revenue Next Year
from 0.10M